-
Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targetsDolšak, Ana, farmacevtka, 1993- ; Gobec, Stanislav, 1970- ; Sova, Matej, 1979-Conversion of tryptophan to N-formylkynurenine is the first and rate-limiting step of the tryptophan metabolic pathway (i.e., the kynurenine pathway). This conversion is catalyzed by three enzyme ... isoforms: indoleamine 2,3-dioxygenase 1 (IDO1), indoleamine 2,3-dioxygenase 2 (IDO2), and tryptophan-2,3-dioxygenase (TDO). As this pathway generates numerous metabolites that are involved in various pathological conditions, IDOs and TDO represent important targets for therapeutic intervention. This pathway has especially drawn attention due to its importance in tumor resistance. Over the last decade, a large number of IDO and TDO inhibitors have been developed, many of which have entered clinical trials. Here, detailed structural comparisons of these three enzymes (with emphasis on their active sites), their involvement in cellular signaling, and their role(s) in pathological conditions are discussed. Furthermore, the most important recent inhibitors described in papers and patents and involved in clinical trials are reviewed, with a focus on both selective and multiple inhibitors. A short overview of the biochemical and cellular assays used for inhibitory potency evaluation is also presented. This review summarizes recent advances on IDO and TDO as potential drug targets, and provides the key features and perspectives for further research and development of potent kynurenine pathway inhibitors.Vir: Pharmacology & therapeutics [Elektronski vir]. - ISSN 1879-016X (Vol. 221, 2021, str. 1-23)Vrsta gradiva - e-članek ; neleposlovje za odrasleLeto - 2021Jezik - angleškiCOBISS.SI-ID - 38739715
Avtor
Dolšak, Ana, farmacevtka, 1993- |
Gobec, Stanislav, 1970- |
Sova, Matej, 1979-
Teme
Imunski sistem |
Rak (medicina) |
indoleamine 2,3-dioxygenase |
tryptophan-2,3-dioxygenase |
kynurenine |
pathwayInhibitors |
immune system |
cancer |
multiple activities |
indolamin2,3-dioksigenaza |
triptofan2,3-dioksigenaza |
kinureninska pot |
zaviralci |
multiplo delovanje
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Dolšak, Ana, farmacevtka, 1993- | 50400 |
Gobec, Stanislav, 1970- | 15284 |
Sova, Matej, 1979- | 25490 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.